Johnson & Johnson’s prescription for growth J&J projects 5-6% revenue growth in 2024, fueled by strong core businesses, acquisitions, and a robust pipeline targeting $57 billion in drug sales by 2025. Previous Article George Santos Is Making Six Figures on Cameo, According to a New Report Next Article Here's How Our Company Tripled in Size By Creating a Culture of Bold Kindness
